Probiotic and Juxtapid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Probiotic (bacillus coagulans) and Juxtapid (lomitapide mesylate). Common drug interactions include liver disorder among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Probiotic and Juxtapid. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Probiotic?

Probiotic has active ingredients of bacillus coagulans. It is often used in irritable bowel syndrome. eHealthMe is studying from 22,462 Probiotic users. Check the latest studies of Probiotic.

What is Juxtapid?

Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

17 people who take Probiotic and Juxtapid together, and have interactions are studied.

Probiotic and Juxtapid drug interactions.

What are the common drug interactions of Probiotic and Juxtapid, by gender? *:

female:

  1. Liver disorder (liver diseases)
  2. Peritonsillar abscess (painful pus filled inflammation of the tonsils and surrounding tissues)
  3. Cough
  4. Decreased appetite
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Hyperchlorhydria (gastric acid levels are higher in stomach)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Oedema peripheral (superficial swelling)

male:

  1. Aspartate aminotransferase increased
  2. Diarrhoea
  3. Influenza
  4. Weight increased

What are the common drug interactions of Probiotic and Juxtapid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Influenza

40-49:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Diarrhoea
  4. Hepatic enzyme increased
  5. Liver disorder (liver diseases)
  6. Nausea (feeling of having an urge to vomit)
  7. Peritonsillar abscess (painful pus filled inflammation of the tonsils and surrounding tissues)
  8. Vomiting

50-59:

  1. Cough
  2. Decreased appetite
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  6. Hyperchlorhydria (gastric acid levels are higher in stomach)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nausea (feeling of having an urge to vomit)
  10. Oedema peripheral (superficial swelling)

60+:

  1. Very low density lipoprotein increased
  2. Weight decreased
  3. Glycosylated haemoglobin increased
  4. Headache (pain in head)
  5. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Infection
  8. Memory impairment
  9. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  10. Retching (strong involuntary effort to vomit)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 3 people, 17.65%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 17.65%
  3. High Blood Pressure: 3 people, 17.65%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
  5. Dyslipidaemia (abnormal amount of lipids): 3 people, 17.65%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 17.65%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
  8. High Blood Cholesterol: 2 people, 11.76%
  9. Depression: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Probiotic and Juxtapid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Probiotic and Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Probiotic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Probiotic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Juxtapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bacillus coagulans and lomitapide mesylate (the active ingredients of Probiotic and Juxtapid, respectively), and Probiotic and Juxtapid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: